Nuvilex Introduces Last Shot Hangover Remedy(TM) Video

CHERRY HILL, N.J., Aug. 27 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC
Bulletin Board: NVLX), today announces that its Last Shot Hangover Remedy(TM)
("Last Shot") video commercial will begin airing on Monday, August 31, 2009.
The video is a part of the Company's emerging Last Shot brand awareness
campaign that will ultimately include television, radio, Internet, cinema
spots, billboard, print and point-of-sale advertising. The video will
initially be introduced to the public through the Internet. The video is
adaptable for long and short segment play. The Last Shot video can be
previewed from the Nuvilex (www.nuvilex.com) and Last Shot
(www.mylastshot.com) web sites starting Friday, August 28, 2009.

About Nuvilex, Inc.

Nuvilex, Inc. is an emerging healthcare consumer products company. The
Company's lead products include: Last Shot Hangover Remedy, a unique
sugar-free, calorie-free and caffeine-free liquid formula designed to ease the
symptoms of a hangover; Cinnergen, which promotes a healthy glucose
metabolism; Cinnechol, designed to help maintain normal cholesterol levels and
support normal cardiovascular function; and Infinitink( (R)), a permanent yet
more easily removable tattoo ink. The Company's complete portfolio spans
aesthetics, skin care, environmental and nutraceutical products, all of which
are designed to directly or indirectly improve human health. In March 2009,
Nuvilex merged with Freedom2 Holdings, Inc., the developer of Infinitink(
(R)). In conjunction with the merger, the Company changed its name to
Nuvilex, Inc. from eFoodSafety.com. Please visit www.nuvilex.com for
additional information on the Company.

Safe Harbor Statement

Statements contained in this presentation that are not strictly historical are
"forward-looking" statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities and Exchange Act of
1934. The forward-looking statements are made based on information available
as of the date hereof, and the Company assumes no obligation to update such
forward-looking statements. Forward-looking statements are sometimes
identified by words such as "intends", "anticipates", "believes", "expects",
and "hopes" and involve a number of risks and uncertainties that could cause
the Company's actual results to differ materially from projected results. All
parties are cautioned that such forward-looking statements involve risks and
uncertainties that could cause the Company's actual results to differ
materially from those in these forward-looking statements. Such risks and
uncertainties include but are not limited to demand for the Company's products
and services, the planned share exchange with Freedom2 Holdings, Inc., our
ability to secure additional financing, and other factors that may be more
fully described in reports to shareholders and periodic filings with the
Securities and Exchange Commission.

Company Contact:

Blair Barnes
Senior Vice President and Chief Financial Officer
Nuvilex, Inc.
Ph: 856-433-6088
Email: bbarnes@nuvilex.com

Press Contact:

Pat Arcand
Arcand & Madison
Ph: 617-576-7777
Email: pat@am-pr.com

SOURCE Nuvilex, Inc.

Company, Blair Barnes, Senior Vice President and Chief Financial Officer of
Nuvilex, Inc., +1-856-433-6088, bbarnes@nuvilex.com; or Press, Pat Arcand of
Arcand & Madison for Nuvilex, Inc., +1-617-576-7777, pat@am-pr.com